Pricing & Availability
- Clone
- 104 (See other available formats)
- Regulatory Status
- RUO
- Other Names
- Ly-5.2, LCA
- Isotype
- Mouse (SJL) IgG2a, κ
- Ave. Rating
- Submit a Review
- Product Citations
- publications
Compare all formats See APC spectral data
Cat # | Size | Price | Quantity Check Availability | Save | ||
---|---|---|---|---|---|---|
109813 | 25 µg | $30.00 | ||||
109814 | 100 µg | $105.00 |
CD45.2 is an alloantigen of CD45, expressed by Ly5.2 bearing mouse strains (e.g., A, AKR, BALB/c, CBA/Ca, CBA/J, C3H/He, C57BL, C57BR, C57L, C58, DBA/1, DBA/2, NZB, SWR, 129). CD45, a member of the protein tyrosine phosphatase (PTP) family, is a 180-240 kD glycoprotein expressed on all hematopoietic cells except mature erythrocytes and platelets. There are multiple isoforms in the mouse that play key roles in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation states of the cell as well as specific cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.
Product Details
Technical data sheet
Product Details
- Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- B10.S mouse thymocytes and splenocytes
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The CD45.2 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC – Quality tested
- Recommended Usage
-
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis6 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Red Laser (633 nm)
- Application Notes
-
The 104 antibody does not react with mouse cells expressing the CD45.1 alloantigen. Additional reported applications (for the relevant formats) include: immunoprecipitation4, in vivo and in vitro blocking of B cell responses1,2, and immunohistochemical staining of acetone-fixed frozen sections3.
- Application References
(PubMed link indicates BioLegend citation)
-
- Yakura H, et al. 1983. J. Exp. Med. 157:1077. (Block)
- Yakura H, et al. 1986. J. Immunol. 136:2729. (Block)
- Suzuki K, et al. 2000. Immunity 13:691. (IHC)
- Shen FW, et al. 1986. Immunogenetics 24:146. (IP)
- Baldwin TA and Hogquist KA. 2007. J. Immunol. 179:837.
- Pascal V, et al. 2007. J. Immunol. 179:1751.
- Burman AC, et al. 2007. Blood 110:1064.
- Kincaid EZ, et al. 2007. J. Immunol. 179:3187.
- Phan TG, et al. 2007. Nature Immunol. 8:992.
- Nakano-Yokomizo T, et al. 2011. J. Exp Med. 208:1661. PubMed
- Wen T, et al. 2013. PNAS. 110:6067. PubMed
- Kohlmeier JE, et al. 2008. Immunity. 29:101. (FC) PubMed
- Product Citations
-
- Degn SE et al. 2017. Cell. 170(5):913-926 . PubMed
- Palazon A, et al. 2017. Cancer Cell. . 10.1016/j.ccell.2017.10.003. PubMed
- Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
- Hirota K et al. 2018. Immunity. 48(6):1220-1232 . PubMed
- Bowers E, et al. 2018. Nat Med. 24:95. PubMed
- Xu X, et al. 2018. Cell. 175:1336. PubMed
- Burrack KS et al. 2018. Immunity. 48(4):760-772 . PubMed
- Kleppe M et al. 2018. Cancer cell. 33(1):29-43 . PubMed
- Habtetsion T et al. 2018. Cell metabolism. 28(2):228-242 . PubMed
- Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
- Cohen SB et al. 2018. Cell host & microbe. 24(3):439-446 . PubMed
- Firl DJ et al. 2018. eLife. 7 pii: e33051. PubMed
- Luo H, et al. 2019. Cell Rep. 26:945. PubMed
- Chen S, et al. 2018. Nat Commun. 9:5298. PubMed
- Hayatsu N et al. 2017. Immunity. 47(2):268-283 . PubMed
- Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
- Timilshina M, et al. 2020. Cell Reports. 27(10):2948-2961.e7.. PubMed
- Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
- Uchimura T et al. 2018. Immunity. 49(6):1049-1061 . PubMed
- Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed
- Radulovic V, et al. 2020. Cell Reports. 27(10):2826-2836.e5.. PubMed
- Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
- Kaplan BLF et al. 2018. Current protocols in toxicology. 75:11:00 25. PubMed
- Yuan X, et al. 2017. Elife. 6:e29540. PubMed
- Lechner AJ et al. 2017. Cell stem cell. 21(1):120-134 . PubMed
- Woodworth JS, et al. 2017. Mucosal Immunol. 0.802083333. PubMed
- van der Poel CE, et al. 2019. Cell Rep. 29:2745. PubMed
- Tsuchiya N, et al. 2020. Cell Reports. 29(1):162-175.e9.. PubMed
- Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
- Zhou L, et al. 2020. Clin Cancer Res. 26:290. PubMed
- Han CY, et al. 2020. Cell Reports. 31(13):107818. PubMed
- Krummey SM, et al. 2020. Cell Reports. 30(5):1282-1291.e5.. PubMed
- Pfirschke C, et al. 2020. Cell Rep. 32:108164. PubMed
- Garaycoechea JI, et al. 2018. Nature. 553:171. PubMed
- Takizawa H, et al. 2011. J Exp Med. 208:273. PubMed
- Markey K, et al. 2012. Blood. 119:5918. PubMed
- Santamaria-Martínez A, et al. 2009. Exp Cell Res. 315:3004. PubMed
- Markey K, et al. 2014. J Immunol. 192:5426. PubMed
- Brocq M, et al. 2014. J Immunol. 192:6120. PubMed
- Guo H, et al. 2014. J Leukoc Biol. 96:419. PubMed
- Schaefer K, et al. 2014. PLoS One. 9:114824. PubMed
- Zhang J, et al. 2015. PLoS One. 10:130441. PubMed
- Koyama M, et al. 2015. J Exp Med. 212: 1303 – 1321. PubMed
- Gordon E, et al. 2015. Proc Natl Acad Sci U S A. 112: 13075 – 13080. PubMed
- Guo Z, et al. 2016. Nat Commun. 7:10307. PubMed
- Kondo M, et al. 2016. J Immunol. 196: 563 – 572. PubMed
- Jutz S, et al. 2016. J Immunol Methods. 430:10-20. PubMed
- Guo H, Cooper S, Friedman A, et al. 2017. PLoS One. 10.1371/journal.pone.0150809. PubMed
- Kalinski AL, et al. 2020. Elife. 9:00. PubMed
- Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
- Fuster JJ, et al. 2020. Cell Rep. 33:108326. PubMed
- Boyd DF, et al. 2020. Nature. 587:466. PubMed
- Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
- Melo-Silva CR, et al. 2021. PLOS Pathogens. 17(5):e1009593. PubMed
- Winkler ES, et al. 2020. Cell. 182(4):901-918.e18. PubMed
- Dufva O, et al. 2020. Cancer Cell. 38(3):380-399.e13. PubMed
- Borges da Silva H, et al. 2020. Immunity. 53(1):158-171.e6. PubMed
- Hirai T, et al. 2020. Immunity. 54(1):84-98.e5. PubMed
- Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
- Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
- Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed
- Deerhake ME, et al. 2021. Immunity. 54(3):484-498.e8. PubMed
- Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
- Levine LS, et al. 2021. Immunity. 54(4):829-844.e5. PubMed
- Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
- Mandal RK, et al. 2021. Cell Reports. 35(6):109094. PubMed
- Qin Q, et al. 2021. Cell Reports. 35(8):109161. PubMed
- Lu SX, et al. 2021. Cell. . PubMed
- Marangoni F, et al. 2021. Cell. . PubMed
- RRID
- AB_389210 (BioLegend Cat. No. 109813)
AB_389211 (BioLegend Cat. No. 109814)
Antigen Details
- Structure
- Protein tyrosine phosphatase (PTP) family, 180-240 kD
- Distribution
-
All hematopoietic cells except mature erythrocytes and platelets of the CD45.2 strain of mice
- Function
- Phosphatase, T and B cell activation
- Ligand/Receptor
- Galectin-1, CD2, CD3, CD4
- Biology Area
- Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers
- Molecular Family
- CD Molecules
- Antigen References
-
1. Suzuki K, et al. 2000. Immunity 13:691.
- Gene ID
- 19264 View all products for this Gene ID
- UniProt
- View information about CD45.2 on UniProt.org
Related Products
Description | Clone | Applications |
---|
Related FAQs
There are no FAQs for this product.
Other Formats
View All CD45.2 Reagents Request Custom Conjugation
Description | Clone | Applications |
---|---|---|
Biotin anti-mouse CD45.2 | 104 | FC |
FITC anti-mouse CD45.2 | 104 | FC |
PE anti-mouse CD45.2 | 104 | FC |
Purified anti-mouse CD45.2 | 104 | FC, Block, IHC-F, IP |
APC anti-mouse CD45.2 | 104 | FC |
Alexa Fluor® 488 anti-mouse CD45.2 | 104 | FC |
Alexa Fluor® 647 anti-mouse CD45.2 | 104 | FC |
Pacific Blue™ anti-mouse CD45.2 | 104 | FC |
Alexa Fluor® 700 anti-mouse CD45.2 | 104 | FC |
APC/Cyanine7 anti-mouse CD45.2 | 104 | FC |
PerCP anti-mouse CD45.2 | 104 | FC |
PerCP/Cyanine5.5 anti-mouse CD45.2 | 104 | FC |
PE/Cyanine7 anti-mouse CD45.2 | 104 | FC |
Brilliant Violet 421™ anti-mouse CD45.2 | 104 | FC |
Brilliant Violet 570™ anti-mouse CD45.2 | 104 | FC |
Brilliant Violet 650™ anti-mouse CD45.2 | 104 | FC |
Brilliant Violet 510™ anti-mouse CD45.2 | 104 | FC |
Brilliant Violet 785™ anti-mouse CD45.2 | 104 | FC |
Brilliant Violet 605™ anti-mouse CD45.2 | 104 | FC |
Purified anti-mouse CD45.2 (Maxpar® Ready) | 104 | FC, CyTOF® |
PE/Dazzle™ 594 anti-mouse CD45.2 | 104 | FC |
Brilliant Violet 711™ anti-mouse CD45.2 | 104 | FC |
Alexa Fluor® 594 anti-mouse CD45.2 | 104 | IHC-F |
APC/Fire™ 750 anti-mouse CD45.2 | 104 | FC |
TotalSeq™-A0157 anti-mouse CD45.2 | 104 | PG |
TotalSeq™-B0157 anti-mouse CD45.2 | 104 | PG |
TotalSeq™-C0157 anti-mouse CD45.2 | 104 | PG |
Brilliant Violet 750™ anti-mouse CD45.2 | 104 | FC |
Spark Blue™ 550 anti-mouse CD45.2 | 104 | FC |
Spark NIR™ 685 anti-mouse CD45.2 | 104 | FC |